Doctor profile · Federal record
Dr. SHAHID AZIZ, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: INTERNAL MEDICINE) · Internal Medicine Physician · SAN ANTONIO, TX
- NPI 1063611697
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 19 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11130 CHRISTUS HILLS, STE 101
SAN ANTONIO, TX 78251
(210) 352-5006
fax (210) 352-5016
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- May 2, 2014
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Texas #P5589 · South Carolina #LL30131
- Medicaid
- TX #327662801
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063611697. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,273
Distinct HCPCS
10
Medicare allowed
$585,952
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,785 | 40 | $23 | |
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 2,231 | 323 | $61 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,149 | 479 | $123 | |
99439 |
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 1,088 | 294 | $46 | |
99454 |
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 592 | 113 | $48 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 577 | 54 | $77 | |
G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes | 480 | 207 | $25 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 410 | 167 | $33 | |
99426 |
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 394 | 68 | $59 | |
99427 |
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 131 | 56 | $46 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 295. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$22,522
Transactions
178
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 26 | $8,671.36 | |
| Lilly USA, LLC | 27 | $6,567.14 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $2,520.87 | |
| CeQur Corporation | 2 | $1,896.55 | |
| Dexcom, Inc. | 18 | $460.20 | |
| AstraZeneca Pharmaceuticals LP | 4 | $266.96 | |
| Tandem Diabetes Care, Inc. | 4 | $265.28 | |
| Amgen Inc. | 15 | $258.43 | |
| Averitas Pharma Inc. | 8 | $254.98 | |
| Novartis Pharmaceuticals Corporation | 16 | $240.22 | |
| Ascensia Diabetes Care Us Inc. | 8 | $222.14 | |
| BETA BIONICS, INC. | 4 | $186.24 | |
| Corcept Therapeutics | 11 | $172.82 | |
| ABBVIE INC. | 10 | $144.63 | |
| SANOFI-AVENTIS U.S. LLC | 5 | $84.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,855
Patients
757
Total drug cost
$2,184,423
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 588 | 131 | $781,258 |
| Levothyroxine Sodium | Generic | 341 | 107 | $5,501 |
| Trulicity (Dulaglutide) | Brand | 234 | 48 | $327,580 |
| Atorvastatin Calcium | Generic | 226 | 68 | $3,162 |
| Tresiba Flextouch U-200 (Insulin Degludec) | Brand | 183 | 51 | $200,397 |
| Metformin Hcl | Generic | 168 | 52 | $1,836 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 159 | 71 | $19,707 |
| Mounjaro (Tirzepatide) | Brand | 150 | 32 | $180,684 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 147 | 42 | $1,570 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 141 | 27 | $117,381 |